









Markets
/
Stocks
/
nasdaq-rdnt
/

RadNet Inc

RDNT

74.560USD

+0.550+0.74%

Market hours （ET）Quotes delayed by 15 min

5.60BMarket Cap

LossP/E TTM



RadNet Inc

74.560

+0.550+0.74%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

26 / 72

Overall Ranking

159 / 4724

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

77.429

Target Price

+4.62%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.94% year-on-year.

Undervalued

The company’s latest PE is -373.02, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 79.67M shares, increasing 2.87% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 7.37M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.56.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 4.97, which is lower than the Healthcare Providers & Services industry's average of 7.15. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 471.40M, representing a year-over-year increase of 9.19%, while its net profit experienced a year-over-year increase of 1264.74%.

Score

Industry at a Glance

Previous score

4.97

Change



Financials

8.29

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.44

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.12

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.00

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 1.20, which is lower than the Healthcare Providers & Services industry's average of 2.15. Its current P/E ratio is -359.31, which is -195.84% below the recent high of 344.35 and 64.55% above the recent low of -127.38.

Score

Industry at a Glance

Previous score

1.20

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 26/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 8.86, which is higher than the Healthcare Providers & Services industry's average of 7.66. The average price target for RadNet Inc is 75.00, with a high of 80.00 and a low of 60.00.

Score

Industry at a Glance

Previous score

8.86

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

77.429

Target Price

+4.62%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

RadNet Inc

RDNT

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 9.84, which is higher than the Healthcare Providers & Services industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 78.37 and the support level at 57.49, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.30

Change

0.33

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.292

Neutral

RSI(14)

68.213

Neutral

STOCH(KDJ)(9,3,3)

84.282

Buy

ATR(14)

1.834

High Vlolatility

CCI(14)

171.020

Buy

Williams %R

6.151

Overbought

TRIX(12,20)

0.751

Sell

StochRSI(14)

75.233

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

72.826

Buy

MA10

72.086

Buy

MA20

70.656

Buy

MA50

62.730

Buy

MA100

59.403

Buy

MA200

61.065

Buy

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 7.19. The latest institutional shareholding proportion is 103.62%, representing a quarter-over-quarter decrease of 4.73%. The largest institutional shareholder is The Vanguard, holding a total of 7.37M shares, representing 9.59% of shares outstanding, with 4.22% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

8.86M

-0.06%

The Vanguard Group, Inc.

Star Investors

7.29M

-1.70%

Kaminsky (Sandy Nyholm)

4.55M

-15.34%

Beck, Mack & Oliver LLC

3.28M

+6.89%

RTW Investments L.P.

2.32M

+17.13%

State Street Global Advisors (US)

2.48M

-2.78%

Stolper (Mark D)

2.36M

+2190.59%

Allspring Global Investments, LLC

1.69M

+14.45%

Geode Capital Management, L.L.C.

1.60M

+3.16%

JB Capital Partners, L.P.

1.47M

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 1.54. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.